framycetin has been researched along with clofibrate in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 42 (87.50) | 18.7374 |
1990's | 1 (2.08) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (10.42) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Passi, RB; Redinger, RN | 1 |
Meinders, AE | 1 |
Gustafsson, BE; Norin, KE | 1 |
Levy, RI | 2 |
Clopath, P; Dicato, MA | 1 |
Augustin, J; Greten, H; Klose, G; Middelhoff, G; Mordasini, R | 1 |
Howard, AN | 1 |
Huttunen, J | 1 |
Ritland, S | 1 |
Sirtori, C | 1 |
Gotto, AM; Yeshurun, D | 1 |
Kane, JP; Malloy, MJ | 1 |
Blum, CB; Levy, RI | 1 |
Nikkilä, EA; Tikkanen, MJ | 1 |
Perry, RS | 1 |
Havel, RJ; Kane, JP | 1 |
Malinow, MR | 1 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Stuyt, PM | 1 |
Lipovetskiĭ, BM; Teriukova, NP; Triufanov, VF | 1 |
Parker, F | 1 |
Levy, RI; Morganroth, J; Rifkind, BM | 1 |
Blaton, V; Declercq, B; Mortelmans, J; Peeters, H; Vandamme, D; Vastesaeger, M; Vercruysse, J | 1 |
Miettinen, TA | 2 |
Krikler, DM | 1 |
Fumagalli, R; Paoletti, R; Sirtori, C | 1 |
Fumagalli, R; Paoletti, R; Sirtori, R | 1 |
Faergeman, O | 1 |
Briani, G; Crepaldi, G; Fellin, R | 1 |
Teoh, PC | 1 |
Likoff, W | 1 |
Lewis, B | 1 |
Holtzman, CM; Meilman, E; Samuel, P; Sekowski, I | 1 |
Schade, RW | 1 |
Samuel, P | 1 |
13 review(s) available for framycetin and clofibrate
Article | Year |
---|---|
The effect of hypolipidemic drugs on plasma lipoproteins.
Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Rats; Sitosterols | 1977 |
Recent progress in atherosclerosis research; experimental and clinical aspects.
Topics: Animals; Anticoagulants; Arteriosclerosis; Blood Platelets; Cell Division; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Endothelium; Humans; Lipoproteins; Neomycin; Nicotinic Acids; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1978 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Drug Therapy, Combination; Estrogens; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids; Thyroxine; Triglycerides | 1975 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides | 1988 |
Contemporary recommendations for evaluating and treating hyperlipidemia.
Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Phenotype; Probucol | 1986 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Treatment of hyperlipidemia.
Topics: Blood Proteins; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Costs and Cost Analysis; Diet Therapy; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Neomycin; Nicotinic Acids; Phospholipids; Sitosterols; Thyroxine; Triglycerides | 1974 |
[Drug prevention of coronary disease].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cholestyramine Resin; Clofibrate; Coronary Disease; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Neomycin | 1972 |
Therapy of lipid disorders.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet Therapy; Drug Therapy, Combination; Female; Hospitals, Psychiatric; Humans; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids; Sex Factors | 1973 |
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lignin; Lipid Metabolism; Lipid Mobilization; Male; Nafenopin; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Progestins; Sitosterols; Sterols; Thyroxine; Triglycerides | 1973 |
Effects of hypolipidemic drugs on bile acid metabolism in man.
Topics: Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fiber; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Plants, Medicinal; Sterols; Thyroxine | 1981 |
[Hyperlipoproteinemia type II].
Topics: Adolescent; Adult; Cecum; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Ileum; Lipoproteins, LDL; Neomycin; Nicotinic Acids; Plasmapheresis; Portacaval Shunt, Surgical; Xanthogranuloma, Juvenile | 1980 |
2 trial(s) available for framycetin and clofibrate
Article | Year |
---|---|
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Drug Therapy, Combination; Estrogens; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids; Thyroxine; Triglycerides | 1975 |
Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin.
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Clofibrate; Constipation; Depression, Chemical; Diarrhea; Drug Therapy, Combination; Dyspepsia; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nausea; Neomycin | 1973 |
34 other study(ies) available for framycetin and clofibrate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Effects of plasma cholesterol lowering agents on hepatobiliary lipid metabolism and cholesterol turnover in the rhesus monkey.
Topics: Animals; Anticholesteremic Agents; Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Female; Haplorhini; Lipid Metabolism; Liver; Macaca mulatta; Neomycin | 1979 |
[Hyperlipoproteinemia].
Topics: Adipose Tissue; Apolipoproteins; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Fatty Acids; Humans; Hyperlipidemias; Lipid Metabolism; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Neomycin; Nicotinic Acids; Phospholipids; Triglycerides | 1979 |
Development of germfree animal characteristics in conventional rats in antibiotics.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Bacitracin; Bile Pigments; Cholestanol; Clofibrate; Colistin; Erythromycin; Feces; Ferrous Compounds; Germ-Free Life; Intestines; Kanamycin; Male; Metronidazole; Neomycin; Oxytetracycline; Penicillin G; Rats; Sorbitol; Sulfathiazoles; Tetracycline | 1977 |
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextrothyroxine; Drug Therapy, Combination; Estrogens; Humans; Hyperlipidemias; Lipoproteins; Neomycin; Nicotinic Acids; Progestins; Sitosterols | 1978 |
[Treatment of hyperlipidemia].
Topics: Adult; Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids | 1976 |
[Treatment of hyperlipoproteinemia].
Topics: Adult; Clofibrate; Dextrothyroxine; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Neomycin; Nicotinic Acids | 1976 |
Lipid-lowering drugs.
Topics: Cellulose; Cholestyramine Resin; Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Lipids; Myocardial Infarction; Neomycin; Nicotinic Acids | 1975 |
[Diet and drug therapy of hyperlipoproteinemia].
Topics: Butyrates; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dietary Fats; Humans; Hyperlipidemias; Hypolipidemic Agents; Neomycin; Nicotinic Acids | 1975 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols | 1976 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol | 1991 |
Rational drug therapy of the hyperlipoproteinemias, Part II.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol | 1986 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Adverse effects of the treatment for hyperlipidemia.
Topics: Anion Exchange Resins; Anticholesteremic Agents; Bibliographies as Topic; Clofibrate; Diet; Drug Therapy, Combination; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Physical Exertion; Probucol; Risk | 1986 |
[Drugs in hyperlipidemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypolipidemic Agents; Neomycin; Niacin | 1987 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides | 1985 |
[Differential use of diet and drugs in dyslipoproteinemias].
Topics: Adult; Clofibrate; Dietary Carbohydrates; Dietary Fats; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipids; Male; Middle Aged; Neomycin | 1985 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |
Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Blood Protein Disorders; Body Weight; Cholesterol; Chylomicrons; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Lipase; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Neomycin; Nicotinic Acids; Sodium; Triglycerides | 1973 |
Comparative treatment of hyperlipoproteinaemias in chimpanzees.
Topics: Animals; Cholesterol; Clofibrate; Diet, Atherogenic; Fatty Acids; Female; Hyperlipidemias; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Neomycin; Pan troglodytes; Phospholipids; Sitosterols; Thyroxine; Triglycerides | 1974 |
[Hypolipemic agents].
Topics: Androgens; Biological Transport; Butyrates; Cholestyramine Resin; Clofibrate; Estrogens; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipid Metabolism; Lipids; Neomycin; Nicotinic Acids; Thyroid Hormones; Triglycerides | 1973 |
Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
Topics: Adolescent; Adult; Alcohol Drinking; Body Weight; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Drug Therapy, Combination; Fats, Unsaturated; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Neomycin; Nicotinic Acids; Sitosterols; Thyroxine | 1973 |
Effect of combined administration of clofibrate and neomycin on serum cholesterol levels in familial type II hyperlipoproteinaemia.
Topics: Adolescent; Adult; Child; Cholesterol; Clofibrate; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Male; Middle Aged; Neomycin | 1973 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Exercise Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Neomycin; Nicotinic Acids; Nitrates; Stress, Physiological; Thyroxine; Triglycerides | 1972 |
Lipid lowering agents.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids | 1972 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Metabolic Clearance Rate; Neomycin; Nicotinic Acids; Obesity; Oxymetholone; Triglycerides | 1971 |
Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.
Topics: Adolescent; Adult; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Drug Synergism; Female; Humans; Hyperlipidemias; Male; Middle Aged; Neomycin; Propionates; Triglycerides | 1970 |
Management of excess serum lipid.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Ileum; Neomycin; Triglycerides | 1971 |
Lipid-lowering drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Probucol | 1980 |
Drug treatment of hyperlipidemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperlipidemias; Middle Aged; Neomycin; Nicotinic Acids; Probucol | 1980 |